![]() |
|||
CLICK HERE TO ENROLL IN A PARKINSON'S DISEASE CLINICAL TRIAL
The
true strength of this unusual research center lies in the caliber of its
scientists and clinicians. Collaborating here are some of the best and
brightest minds in the world, all working to defeat Parkinson's disease.
The Center is under the direction of Ted Dawson, M.D., Ph.D. (at left),
Dawson and his group have made many important discoveries that are leading
to the development of new drugs, some of which may be used in the future
to treat and/or cure PD. The Center uses animal and cellular models of
Parkinson's disease (PD) to develop innovative therapies for patients
suffering from this condition. Using cell, organ and animal models to
test therapies is a swift lead-in to human studies and Johns Hopkins has
held more than a dozen major human trials of drugs for PD and other neurodegnerative
diseases. Thanks to its location at the Johns Hopkins School of Medicine,
the Center has the institutional machinery in place to run conclusive
studies. Its scientists
also study mechanisms of neuroprotection, regeneration and repair, including
stem cell researchThe Center investigators are leaders in their fields. Many are recognized world-wide for their expertise in such fields as neuronal injury, differential gene expression and dynamic gene regulation, protein interactions, neuropathology and the development of animal models of human neurodegenerative diseases. |
|||